PEEPS: Endometriosis Group Care

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05622955
Collaborator
National Institutes of Health (NIH) (NIH)
40
1
24

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to test the effectiveness of the Peer Empowered Endometriosis Pain Support (PEEPS) program in people living with endometriosis-related pelvic pain. The main question[s] it aims to answer are:

  • Is PEEPS effective at decreasing pain interference and improving patient-reported quality of life outcomes?

  • What are the barriers and facilitators to PEEPS implementation? Participants will engage in eight weekly 2-hour sessions led by an endometriosis specialist, pain psychologist, pelvic floor physical therapist, and yoga instructor. At these sessions they will participate in peer support, education, mindfulness, and yoga.

Condition or Disease Intervention/Treatment Phase
  • Other: Peer Empowered Endometriosis Pain Support (PEEPS)
N/A

Detailed Description

This is an 8 week interdisciplinary, integrative group care program conducted through the Department of Obstetrics and Gynecology (OB/GYN) at Washington University in St. Louis (WUSTL). The program, called PEEPS, incorporates mindfulness, physical therapy, yoga, physical activity, nutrition, and education. Additionally, PEEPS will provide peer support and demonstrate investment of individual clinicians and the healthcare system.

The program focuses on equipping participants with pain management and coping skills so they have an expanded toolkit to manage their pain after completing the program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Novel Approach to Endometriosis Treatment: Piloting an Interdisciplinary Group Care Model
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Endometriosis group care

Groups of 6-10 patients with endometriosis and chronic pelvic pain will attend eight weekly two-hour sessions.

Other: Peer Empowered Endometriosis Pain Support (PEEPS)
The sessions will provide education on endometriosis, mindfulness, yoga, nutrition, and strategies to cope with chronic pain. Patients will additionally receive peer and clinician support to decrease the social isolation experienced by people with endometriosis

Outcome Measures

Primary Outcome Measures

  1. Pain Interference [8 weeks]

    Change in reported pain after PEEPS program completion by Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference

Secondary Outcome Measures

  1. Physical Function [8 weeks]

    Change in reported physical function, measured by the PROMIS Physical Function Scale

  2. Sexual Function [8 weeks]

    Change in reported sexual function, measured by the Female Sexual Function Index

  3. Endometriosis-specific quality of life [8 weeks]

    Endometriosis-specific quality of life, measured by Endometriosis Health Profile-30

  4. Anxiety [8 weeks]

    Change in reported anxiety, measured by the PROMIS Anxiety Scale

  5. Depression [8 weeks]

    Change in reported depression, measured by the PROMIS Depression Scale

  6. Pain Catastrophizing [8 weeks]

    Change in reported catastrophizing, measured by the Pain Catastrophizing Scale

  7. Overall symptom improvement [8 weeks]

    Change in overall symptoms, measured by the Patient Global Impression of Change Scale

  8. Modified every day discrimination scale [Baseline]

    To assess experiences of healthcare discrimination

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 48 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-48 years

  • Operative confirmation of endometriosis

  • Chronic pelvic pain (defined as pain perceived to originate from the pelvis, lasting ≥6 months)

  • No plan to have surgery in next 12 weeks

  • Be able to attend eight 2-hour weekly sessions on the Washington University campus

Exclusion Criteria:
  • Non-English speaking

  • Currently pregnant

  • Severe physical impairment

  • History of hip or spine surgery

  • Opioid use ≥ 5 days in the past 3 months, other than for the 6-week post-operative period

  • Current or history of psychiatric disorder with psychosis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Washington University School of Medicine
  • National Institutes of Health (NIH)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT05622955
Other Study ID Numbers:
  • 202206202
First Posted:
Nov 21, 2022
Last Update Posted:
Nov 21, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 21, 2022